Summit Medical

Founded in 1984 and based in Gloucestershire, Summit Medical specializes in innovative orthopaedic solutions, focusing on improving outcomes in joint replacement surgeries through advanced technology and high-quality products. Summit Medical Ltd is dedicated to the design, manufacture, and distribution of orthopaedic products. Founded in 1984 in Gloucestershire, UK, the company has undergone strategic pivots including a Secondary Buyout in March 2018 involving The Riverside Company, raising GBP 36. 000 mn in total.

Chris Lee serves as the CEO, leading the firm through its evolving business landscape, with a total of 4 deals to date. Summit Medical Ltd specializes in high-quality orthopaedic solutions to enhance patient outcomes in joint replacement procedures. Their flagship products include the Torsional Orthopaedic Revision System (TORS) and Dual Mode Ultrasound for Revision of Cemented Endoprosthesis, recently introduced in the U. S.

, addressing key challenges in the field. The company serves a diverse clientele including clinicians, hospitals, and healthcare providers in over 40 countries, emphasizing their commitment to delivering innovative medical products. In the most recent year, 2023, Summit Medical Ltd reported no revenue, with a projected EBITDA of GBP -321,904. 4 for 2024.

The company generates revenue through direct sales of its products to healthcare institutions, focusing on B2B transactions, and engages in partnerships with leading orthopaedic firms to enhance their offerings. Summit Medical plans to launch new products aimed at enhancing joint replacement outcomes, with specific timelines for release yet to be disclosed. The company is also exploring expansion into new geographic markets, targeting regions where orthopaedic technology adoption is growing. The GBP 36.

000 mn raised in the latest funding round will support these initiatives, following the management acquisition of OrthoD Group Ltd from Riverside Company in March 2018.